New Market Study Published: Male Cancer - Pipeline Review, H2 2012
Global Markets Direct's, 'Male Cancer - Pipeline Review, H2 2012', provides an overview of the Male Cancer therapeutic pipeline. This report provides information on the therapeutic development for Male Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Male Cancer. 'Male Cancer - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor...
View full press release